Diabetes Care Devices Industry Insights: Market Forecast to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Is The Diabetes Care Devices Market Size Likely To Evolve From 2025 Through 2034?

The sector dedicated to diabetes treatment apparatus has experienced swift expansion lately, projected to escalate its valuation from 66.46 billion USD in 2024 to 73.91 billion USD the following year, reflecting an 11.2% annualized growth rate. This historical upward trajectory is fundamentally driven by several factors, including the rising incidence of diabetes globally, broader economic development, modifications in publicly funded health coverage systems, a growing elderly demographic, and augmented spending within the healthcare domain.

The sector dedicated to diabetes care apparatus is projected to experience swift expansion in the ensuing years, reaching a market valuation of $115.94 billion by 2029, underpinned by a compound annual growth rate (CAGR) of 11.9%; this upward trajectory throughout the projection timeframe stems from amplified spending on research and development alongside collaborative research efforts, a rising prevalence of the condition globally, supportive governmental programs, and continuous advancements in technology, while significant market shifts anticipated during this period encompass innovations like testing methods that eliminate the need for skin pricking, glucose-responsive insulins (GRIS), automated artificial pancreas systems, the transition away from conventional insulin delivery mechanisms such as syringes, the emergence of wearable and mobile glucose tracking solutions, and the introduction of sophisticated glucose meters.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3609&type=smp

Which Industry Drivers Are Expected To Accelerate The Diabetes Care Devices Market From 2025 To 2029?

Anticipated escalations in spending allocated to healthcare are poised to fuel the expansion of the market for diabetes care devices as we move ahead. This healthcare expenditure encompasses the aggregate sums disbursed for services, commodities, and undertakings related to health across defined timeframes, scalable from individual to global metrics. Higher outlays on healthcare, combined with enhanced availability of medical services and a greater number of diabetes identifications, spur increased capital infusion into research endeavors, thus promoting the evolution of diabetes management technologies like superior blood sugar tracking tools, apparatus for insulin administration, and modern digital wellness platforms. To illustrate this trend, Eurostat, an official body based in Europe, reported in November 2023 that spending dedicated to social protection for illness and medical care within the European Union amounted to 8.1% of its Gross Domestic Product in 2022. Out of the twenty-four EU nations providing figures, France registered the peak spending level at 10.0%, closely followed by Germany at 9.7%, whereas Bulgaria registered the lowest proportion at 4.2%. Nations reporting relatively modest spending levels included Ireland (at 4.6%), Hungary and Lithuania (both at 4.7%), and Estonia (at 4.8%). Consequently, the upward trend in healthcare spending is expected to be a primary catalyst for the progression of the diabetes care device market from this point onward.

What Are The Major Segments Identified In The Diabetes Care Devices Market?

The diabetes care devicesmarket covered in this report is segmented –

1) By Type: Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meters

2) By Type of Expenditure: Public, Private

3) By Product: Instruments Or Equipment, Disposables

4) By Type Of Testing: Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing

5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Blood Glucose Test Strips: Standard Blood Glucose Test Strips, Test Strips for Continuous Glucose Monitors

2) By Insulin Pens: Pre-filled Insulin Pens, Reusable Insulin Pens, Smart Insulin Pens

3) By Syringes: Insulin Syringes (various capacities), Disposable Syringes, Safety Syringes

4) By Pumps and Injectors: Insulin Pumps, Insulin Jet Injectors, Patch Pumps

5) By Lancing Devices and Equipment: Manual Lancing Devices, Automatic Lancing Devices, Lancets (various gauges)

6) By Continuous Glucose Monitoring Devices and Equipment: Real-Time CGM Systems, Flash Glucose Monitoring Systems, CGM Sensors and Transmitters

7) By Blood Glucose Meters: Standard Blood Glucose Meters, Smart Blood Glucose Meters, Meters with Integrated Data Management

Which Market Trends Are Creating New Opportunities In The Diabetes Care Devices Industry?

Leading firms within the diabetes management equipment sector are channeling efforts into creating cutting-edge offerings, exemplified by the Medtronic Extended Infusion, aiming to boost their revenue generation within this space. The Medtronic Extended Infusion Set functions as the conduit transmitting insulin from the pump mechanism to the patient’s system, engineered specifically to remain effective for a maximum duration of seven days. To illustrate, in November of 2022, Medtronic, an American medical technology corporation, introduced this Medtronic Extended infusion set to the market. Through the incorporation of sophisticated components, the Medtronic Extended infusion set is engineered to mitigate the degradation of insulin preservatives and improve fluid transmission, thereby achieving a twofold extension in the usable life of the set. Its novel construction incorporates a completely new tube connection element and a robust skin adhesive, which collectively guarantee insulin integrity and patient comfort across the full seven-day period.

Which Major Industry Participants Are Leading The Diabetes Care Devices Market Growth?

Major companies operating in the diabetes care devices market include Becton Dickinson and Company, Roche Holding AG, Nipro Corporation, HTL-STREFA Inc., ARKRAY, Terumo Corporation, Owen Mumford, Ypsomed AG, Vogt Medical, Sanofi India, Biocon Ltd, Mehar healthcare, Johnson & Johnson, Shandong WeiGao Group Medical Polymer Company Limited, Yuwell medical equipment & supply Co, Medtronic, Emperra GmbH E-Health, Novo Nordisk A/S, Insujet, Eli Lilly, Fresenius Medical Care, Siemens, Stryker, Teleflex Medical, LifeScan, Ascensia Diabetes Care, Tandem Diabetes Care, Dexcom Inc., SocialDiabetes, Dottli, Themis Bioscience, Ok biotech, Acon Laboratories, Bayer AG, AgaMatrix.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report

How Do Regional Market Performances Compare Within The Diabetes Care Devices Industry?

North America was the largest region in the global diabetes care devices market in 2024. Western Europe was the second largest region in the global diabetes care devices market. The regions covered in the diabetes care devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request A Customized Version Of The Diabetes Care Devices Market Report:

https://www.thebusinessresearchcompany.com/customise?id=3609&type=smp

Browse Through More Reports Similar to the Global Diabetes Care Devices Market 2025, By The Business Research Company

Veterinary Anti Infectives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-anti-infectives-global-market-report

Animal Antibiotics And Antimicrobials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/animal-antibiotics-and-antimicrobials-global-market-report

Veterinary Antibiotics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/veterinary-antibiotics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795